We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA PROPOSES LABELING CHANGES TO OTC RECTAL PRODUCTS
FDA PROPOSES LABELING CHANGES TO OTC RECTAL PRODUCTS
March 23, 2004
The FDA wants the manufacturers of OTC rectal drugs to add sodium content and warning information to labeling because the products have caused adverse events in people with certain medical conditions.